Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line

Endocrinology

Volumn 140, Issue 12, 1999, Pages 5579-5586

  Gori, Francesca ^a   Hofbauer, Lorenz C ^a   Conover, Cheryl A ^a   Khosla, Sundeep ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; HYDROXYFLUTAMIDE; PRASTERONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; TESTOSTERONE;

ARTICLE; BONE METABOLISM; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL;

EID: 0033304663     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.12.7213     Document Type: Article

References (61)

1. Androgens in men: Uses and abuses
2. Androgens
3. Effect of excess endogenous androgens on bone density in young women
4. Bone mass and its relationship to age and the menopause
5. Bone and mineral metabolism in aged male rats: Short and long term effects of androgen deficiency
6. Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling
7. A unitary model for involutional osteporosis: Estrogen deficiency causes both type I and type I osteoporosis in postmenopausal women and contributes to bone loss in aging men
8. Osteoporosis in men with hyperprolactinaemic hypogonadism
9. Long term effect of testosterone therapy on bone mineral density in hypogonadal men
10. Treatment of isolated hypogonadotropic hypogonadism: Effect on bone mineral density and bone turnover
11. Androgen-stimulated pubertal growth: The effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty
12. The impact of gonadal steroid secretion during childhood and adolescence
13. Sex differences in peak adult bone mineral density
14. Effect of age on bone density and bone turnover in men
15. Androgens and bone
16. The receptor, metabolism and effects of androgen in osteoblastic MC3T3-E1 cells
17. Identification of androgen receptors in normal human osteoblastic-like cells
18. Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells
19. Androgens regulate bone resorption activity of isolated osteoclast in vitro
20. Regulation of interleukin-6, osteoclastogenesis, bone mass by androgens: The role of the androgen receptor
21. The role of insulin-like growth factors and binding proteins in bone cell biology
22. Insulin-like growth factors and local regulation of bone formation
23. Growth factors for bone growth and repair: IGF, TGFβ and BMP
24. Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates
25. Insulin-like growth factors I and II peptide, messanger ribonucleic acid and gene structure and tissue concentrations
26. Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type I IGF receptor
27. Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone
28. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose 6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: Autocrine growth stimulation by IGF-II via the IGF-I receptor
29. The presence of classical insulin-like growth factor (IGF) type-I and type-II receptor on mouse osteoblasts: Autocrine/paracrine growth effect of IGFs
30. The endocrinology and the developmental biology of the prostate
31. Role of peptide growth factors in the prostate
32. Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: Characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog
33. Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: Relation with binding proteins 2 and 3 and androgens
34. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6)
35. Insulin-like growth factor binding proteins in bone cells regulation
36. Insulin-like growth factor binding proteins and their role controlling IGF actions
37. Changes in insulin-like growth factor binding protein expression and secretion during proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts
38. Regulation of insulin-like growth factor-5 messanger ribonucleic acid expression and protein availability in rat osteoblast-like cells
39. Potential mechanism of estrogen-mediated decrease in bone formation: Estrogen increases production of inhibitory insulin-like growth factor binding protein-4 in a human osteoblastic cell line with high levels of estrogen receptors
40. Skeletal growth factors regulate the synthesis of insulin-like growth factor binding protein-5 in bone cell cultures
41. Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblastic-like cells is cell line specific
42. Development and characterization of a conditionally immortalized human fetal osteoblastic cell line
43. Immortalized osteoblast cell system (new human fetal osteoblast systems)
44. Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor gene
45. Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor
46. A technique for radiolabeling DNA restrictionmendonuclease fragments to high specific activity
47. Fast hybridization solution for the detection of immobilized nucleic acids
48. Nuclear RNA polymerase activities and poly(A)-containing mRNA accumulation in cultured AKR mouse embryo cells stimulated to proliferate
49. Molecular and cellular aspects of the insulin-like growth factor I receptor
50. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): Positive correlation with the presence of the GH-induced IGF-binding protein BP-3
51. Intact but not truncated insualin-like growth factor binding protein-3 (IGFBP-3) blocks IGF-I-induced stimulation of osteoblast: Control of IGF signaling to bone cells by IGFBP-3-specific proteolysis?
52. Transfection of the human insulin-like growth factor binding protein-3 gene into BALB/c fibroblasts inhibits cellular growth
53. Potentiation of insulin-like growth factor (IGF) action by IGF binding protein-3: Studies of underlying mechanism
54. Testosterone stimulates insulin-like growth factor-I and insulin-like growth factor-I-receptor gene expression in the mandibular condyle: A model of endochondral ossification
55. Estrogen response in the hFOB 1.19 human fetal osteoblastic cell lithe stably transfected with the human estrogen receptor gene
56. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line
57. 281]insulin-like growth factor binding protein-2 inhibits both basal and insulin-like growth factor-I-stimulated proliferation and collagen synthesis in fetal rat calvariae
58. 1 on bone formation in cultured fetal rat calvaria: Role of insulin-like growth factor-I
59. Insulin-Like growth factor binding protein-2 -3 stimulate growth hormone receptor binding mitogenesis in rat osteosarcoma cells
60. Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis
61. Response of bipotential human marrow stromal cells to insulin-like growth factors; Effects on binding protein production, proliferation, and commitment to osteoblasts and adipocytes